News global trials of Astrazeneca vaccine

As COVID19 vaccine trials has raised hopes for the World, crippled by a virus. But even after showing 90% efficacy in late trials, the British drug maker likely to run an additional global trial to excess the efficacy of its COVID 19 vaccine. The update comes from Astrazeneca's chief executive Pascal Soriot.